So this is it for our drug development programme, we started with an idea and a number of years later we are ready to try treat multiple sclerosis.
So you have your trial design and you eligibility criteria and you are ready for doing a phase II study in people with MS. This is to test the efficacy of the drug and also to check safety.
If (let’s be hopeful and say when) this works then we are ready for the next step, so we will have to raise funds to do the pivotal Phase III trials.
This is the basis process that pharma will do to develop drugs to you. This is the end of our story so far.
When will ours be ready to go…Sometime in early 2015
CoI We are developing a drug for symptom control